Olanzapine + Placebo

Phase 3Completed

1 views this week 0 watching⚡ Active

Interest: 40/100

Hype Score

Development Stage

✓

Pre-clinical

✓

Phase 1

✓

Phase 2

Phase 3

Approved

Indication / Disease

Depression, Bipolar

Conditions

Depression, Bipolar

Trial Timeline

Aug 1, 2007 → Jul 1, 2010

NCT ID

NCT00510146

About Olanzapine + Placebo

Olanzapine + Placebo is a phase 3 stage product being developed by Eli Lilly for Depression, Bipolar. The current trial status is completed. This product is registered under clinical trial identifier NCT00510146. Target conditions include Depression, Bipolar.

What happened to similar drugs?

13 of 20 similar drugs in Depression, Bipolar were approved

Approved (13) Terminated (2) Active (6)

🔄Olanzapine and Fluoxetine combination (OFC) + FluoxetineEli LillyPhase 3

✅DuloxetineEli LillyApproved

🔄FK949EAstellas PharmaPhase 3

🔄duloxetine + escitalopram + placeboEli LillyPhase 3

✅duloxetineEli LillyApproved

🔄Duloxetine HydrochlorideEli LillyPhase 3

✅DuloxetineEli LillyApproved

Hype Score Breakdown

Clinical

Activity

Company

Novelty

Community

Clinical Trials (6)

NCT ID	Phase	Status	Start	Completion	Indication
NCT00520507	Approved	Completed	Oct 1, 2007	May 1, 2009	Bipolar Disorder
NCT00510146	Phase 3	Completed	Aug 1, 2007	Jul 1, 2010	Depression, Bipolar
NCT00091650	Phase 3	Completed	Mar 1, 2004	Nov 1, 2005	Borderline Personality Disorder
NCT00051298	Phase 3	Completed	Nov 1, 2002	Apr 1, 2005	Schizophrenia
NCT00050206	Approved	Completed	Nov 1, 2002	May 1, 2005	Bipolar Disorder
NCT00592930	Approved	Completed	Jun 1, 2000	Dec 1, 2004	Anorexia Nervosa

Competing Products

20 competing products in Depression, Bipolar

See all competitors

Product	Company	Stage	Hype Score
Olanzapine and Fluoxetine combination (OFC) + Fluoxetine	Eli Lilly	Phase 3	40
Duloxetine	Eli Lilly	Approved	35
FK949E	Astellas Pharma	Phase 3	40
Quetiapine	Astellas Pharma	Pre-clinical	26
duloxetine + escitalopram + placebo	Eli Lilly	Phase 3	40
duloxetine	Eli Lilly	Approved	43
Duloxetine Hydrochloride	Eli Lilly	Phase 3	40
Duloxetine	Eli Lilly	Approved	43
Duloxetine	Eli Lilly	Approved	43
Venlafaxine (Effexor), Duloxetine (Cymbalta), Escitalopram (Lexapro)	Eli Lilly	Approved	43
Duloxetine + Placebo	Eli Lilly	Phase 3	40
Duloxetine	Eli Lilly	Approved	43
duloxetine + fluoxetine + citalopram + paroxetine + sertraline	Eli Lilly	Approved	43
Olanzapine + Fluoxetine + Placebo	Eli Lilly	Phase 3	32
duloxetine + duloxetine	Eli Lilly	Pre-clinical	26
olanzapine + ziprasidone	Eli Lilly	Approved	43
Olanzapine Fluoxetine Combination (OFC) + Placebo	Eli Lilly	Approved	43
Drug treatment with Cymbalta	Eli Lilly	Approved	39
Duloxetine	Eli Lilly	Approved	43
Duloxetine	Eli Lilly	Approved	39